Xylem (XYL) Common Equity (2010 - 2026)

Xylem has reported Common Equity for 17 years, with the latest figure at $10.4 billion in Q2 2026.

• On a quarterly basis, Common Equity fell 5.93% year-over-year to $10.4 billion in Q2 2026; TTM through Jun 2026 was $10.4 billion, a 5.93% decrease from a year earlier, with the FY2025 full-year figure at $11.5 billion, up 7.93% from the prior year.
• Common Equity was $10.4 billion for Q2 2026 at Xylem, down from $11.0 billion in the prior quarter.
• The five-year high for Common Equity was $11.5 billion in Q4 2025, with the low at $3.2 billion in Q2 2022.
• Average Common Equity over 5 years is $8.6 billion, with a median of $10.3 billion recorded in 2024.
• The sharpest annual moves came in 2023 and 2026: Common Equity soared 209.4% in 2023, then slipped 5.93% in 2026.
• Over 5 years, Common Equity stood at $3.5 billion in 2022, then jumped by 190.49% to $10.2 billion in 2023, then increased by 4.63% to $10.6 billion in 2024, then advanced by 7.93% to $11.5 billion in 2025, then declined by 9.29% to $10.4 billion in 2026.
• The last three Common Equity figures came in at $10.4 billion (Q2 2026), $11.0 billion (Q1 2026), and $11.5 billion (Q4 2025), per Business Quant data.